Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 13 | 2017 | 2903 | 1.470 |
Why?
|
| Motor Activity | 4 | 2014 | 327 | 0.880 |
Why?
|
| Cartoons as Topic | 1 | 2014 | 3 | 0.490 |
Why?
|
| Body Mass Index | 4 | 2013 | 770 | 0.480 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2013 | 45 | 0.470 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 28 | 0.460 |
Why?
|
| Health Education | 1 | 2014 | 101 | 0.450 |
Why?
|
| Reproductive Physiological Phenomena | 1 | 2012 | 4 | 0.440 |
Why?
|
| Health Promotion | 2 | 2014 | 160 | 0.440 |
Why?
|
| Walking | 2 | 2010 | 87 | 0.440 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 261 | 0.430 |
Why?
|
| Lactation | 1 | 2012 | 53 | 0.430 |
Why?
|
| Breast Feeding | 1 | 2012 | 91 | 0.410 |
Why?
|
| Breast | 1 | 2013 | 288 | 0.400 |
Why?
|
| Gasoline | 1 | 2011 | 3 | 0.400 |
Why?
|
| Feeding Behavior | 1 | 2014 | 324 | 0.390 |
Why?
|
| Environment Design | 1 | 2010 | 9 | 0.380 |
Why?
|
| Bicycling | 1 | 2010 | 12 | 0.380 |
Why?
|
| Running | 1 | 2010 | 25 | 0.370 |
Why?
|
| Diabetes Complications | 1 | 2012 | 207 | 0.370 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 1056 | 0.360 |
Why?
|
| Mastectomy | 3 | 2017 | 243 | 0.350 |
Why?
|
| Residence Characteristics | 1 | 2010 | 197 | 0.330 |
Why?
|
| Risk Factors | 7 | 2014 | 5417 | 0.300 |
Why?
|
| Female | 22 | 2017 | 44533 | 0.280 |
Why?
|
| United States | 9 | 2017 | 6672 | 0.280 |
Why?
|
| Longitudinal Studies | 4 | 2013 | 1019 | 0.260 |
Why?
|
| Case-Control Studies | 3 | 2014 | 1805 | 0.250 |
Why?
|
| Logistic Models | 4 | 2017 | 1186 | 0.230 |
Why?
|
| Young Adult | 7 | 2015 | 5976 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2271 | 0.220 |
Why?
|
| Adult | 14 | 2015 | 25648 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1373 | 0.210 |
Why?
|
| Humans | 23 | 2017 | 86644 | 0.210 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2017 | 292 | 0.200 |
Why?
|
| Odds Ratio | 2 | 2013 | 678 | 0.200 |
Why?
|
| Body Weight | 3 | 2013 | 459 | 0.200 |
Why?
|
| Surveys and Questionnaires | 5 | 2014 | 2501 | 0.190 |
Why?
|
| Middle Aged | 10 | 2017 | 25028 | 0.170 |
Why?
|
| Adolescent | 8 | 2015 | 8981 | 0.160 |
Why?
|
| Receptors, Progesterone | 2 | 2017 | 167 | 0.150 |
Why?
|
| Aged | 7 | 2017 | 18415 | 0.150 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 150 | 0.140 |
Why?
|
| Nigeria | 2 | 2013 | 152 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2017 | 223 | 0.130 |
Why?
|
| Overweight | 2 | 2006 | 118 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2013 | 4214 | 0.130 |
Why?
|
| Africa | 1 | 2014 | 98 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 81 | 0.120 |
Why?
|
| Literature | 1 | 2014 | 3 | 0.120 |
Why?
|
| New York City | 1 | 2014 | 59 | 0.120 |
Why?
|
| Occupational Exposure | 1 | 2015 | 80 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 217 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2017 | 380 | 0.120 |
Why?
|
| Life Style | 1 | 2015 | 189 | 0.120 |
Why?
|
| Vegetables | 1 | 2014 | 45 | 0.120 |
Why?
|
| Fruit | 1 | 2014 | 75 | 0.120 |
Why?
|
| Premenopause | 1 | 2013 | 54 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 157 | 0.120 |
Why?
|
| Parity | 1 | 2013 | 93 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 182 | 0.110 |
Why?
|
| Postmenopause | 1 | 2013 | 98 | 0.110 |
Why?
|
| Registries | 2 | 2014 | 702 | 0.110 |
Why?
|
| Indians, North American | 1 | 2013 | 48 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 144 | 0.110 |
Why?
|
| Tanzania | 1 | 2012 | 45 | 0.110 |
Why?
|
| Age Distribution | 1 | 2013 | 204 | 0.110 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2012 | 10 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2013 | 135 | 0.110 |
Why?
|
| SEER Program | 1 | 2013 | 190 | 0.110 |
Why?
|
| Students | 1 | 2014 | 147 | 0.110 |
Why?
|
| Carcinoma | 1 | 2015 | 436 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2014 | 267 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 252 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2015 | 533 | 0.100 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 158 | 0.100 |
Why?
|
| Obesity | 2 | 2008 | 963 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 200 | 0.100 |
Why?
|
| Social Class | 1 | 2011 | 128 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 6509 | 0.090 |
Why?
|
| Mammography | 1 | 2013 | 463 | 0.090 |
Why?
|
| Male | 9 | 2014 | 40966 | 0.090 |
Why?
|
| Survivors | 1 | 2011 | 226 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 329 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 394 | 0.090 |
Why?
|
| Urban Population | 1 | 2010 | 213 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 3640 | 0.080 |
Why?
|
| Energy Intake | 1 | 2008 | 98 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1577 | 0.080 |
Why?
|
| Weight Gain | 1 | 2008 | 123 | 0.080 |
Why?
|
| Prognosis | 2 | 2015 | 3679 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1313 | 0.080 |
Why?
|
| Child | 4 | 2014 | 6927 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2014 | 730 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 711 | 0.080 |
Why?
|
| Age Factors | 4 | 2017 | 1851 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 1939 | 0.070 |
Why?
|
| Pregnancy | 1 | 2013 | 2894 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2013 | 2261 | 0.070 |
Why?
|
| Body Composition | 1 | 2005 | 68 | 0.070 |
Why?
|
| Child Behavior | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 1621 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2005 | 106 | 0.060 |
Why?
|
| Health Behavior | 1 | 2005 | 183 | 0.060 |
Why?
|
| Exercise | 1 | 2005 | 315 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2017 | 2767 | 0.040 |
Why?
|
| Mastectomy, Segmental | 1 | 2017 | 93 | 0.040 |
Why?
|
| Neoplasms | 1 | 2011 | 2898 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 468 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 384 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 859 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 21 | 0.030 |
Why?
|
| Sacroiliitis | 1 | 2014 | 3 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 999 | 0.030 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2014 | 24 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 421 | 0.030 |
Why?
|
| Ileal Diseases | 1 | 2014 | 25 | 0.030 |
Why?
|
| Arthralgia | 1 | 2014 | 36 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 94 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 486 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 814 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 552 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 8489 | 0.030 |
Why?
|
| Barbados | 1 | 2012 | 7 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 361 | 0.030 |
Why?
|
| Guam | 1 | 2011 | 1 | 0.030 |
Why?
|
| West Indies | 1 | 2011 | 4 | 0.030 |
Why?
|
| Sex Factors | 2 | 2005 | 1054 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1686 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1863 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 526 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 294 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 107 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 219 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1163 | 0.020 |
Why?
|
| Self Report | 1 | 2011 | 288 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1036 | 0.020 |
Why?
|
| Chicago | 1 | 2014 | 1379 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 567 | 0.020 |
Why?
|
| Leisure Activities | 1 | 2008 | 8 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 40 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1801 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 2330 | 0.020 |
Why?
|
| Educational Status | 1 | 2008 | 188 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2378 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3030 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 1851 | 0.020 |
Why?
|
| Russia | 1 | 2006 | 25 | 0.020 |
Why?
|
| Brazil | 1 | 2006 | 69 | 0.020 |
Why?
|
| Australia | 1 | 2006 | 99 | 0.020 |
Why?
|
| United Kingdom | 1 | 2006 | 164 | 0.020 |
Why?
|
| China | 1 | 2006 | 228 | 0.020 |
Why?
|
| Health Surveys | 1 | 2006 | 239 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 307 | 0.020 |
Why?
|
| Rural Population | 1 | 2005 | 136 | 0.020 |
Why?
|
| Smoking | 1 | 2008 | 609 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 938 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 268 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 1239 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1721 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 2705 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 5210 | 0.010 |
Why?
|